SCHEMBL19942820

SCHEMBL19942820

CCNc1ccc2c(c1)Sc1cc(OC)ccc1N2C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 6/20 0.49
▸ SNCA P37840 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ PIM1 P11309 2/20 0.37
▸ CSNK1D P48730 2/20 0.37
▸ CSNK1E P49674 2/20 0.37
▸ CLK1 P49759 2/20 0.37
▸ CLK3 P49761 2/20 0.37
▸ CSNK1G2 P78368 2/20 0.37
▸ DYRK1A Q13627 2/20 0.37
▸ MAP3K19 Q56UN5 2/20 0.37
▸ PIM3 Q86V86 2/20 0.37
▸ DYRK1B Q9Y463 2/20 0.37
▸ CSNK1G3 Q9Y6M4 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19939646 0.92 BCHE (0.47) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL29403748 0.89 BCHE (0.45) BCHESNCAALDH1A1MAPTHSD17B10
SCHEMBL19918206 0.89 BCHE (0.45) BCHESNCAALDH1A1MAPTHSD17B10
SCHEMBL30858755 0.81 BCHE (0.54) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL30858752 0.81 BCHE (0.54) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL29406451 0.81 SNCA (0.60) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL19918106 0.81 SNCA (0.60) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL14142982 0.79 BCHE (0.61) BCHESNCAACHE
SCHEMBL30196010 0.77 BCHE (0.46) BCHESNCAALDH1A1KDM4ETP53
SCHEMBL19918214 0.77 BCHE (0.46) BCHESNCAALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220081404-A1 PHENOTHIAZINE ANALOGUES AS MITOCHONDRIAL THERAPEUTIC AGENTS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-03-17 — — US disclosed
US-10472340-B2 Substituted phenothiazines as mitochondrial agents ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-11-12 — — US disclosed
US-20180065941-A1 PHENOTHIAZINE ANALOGUES AS MITOCHONDRIAL THERAPEUTIC AGENTS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065941-A1 PHENOTHIAZINE ANALOGUES AS MITOCHONDRIAL THERAPEUTIC AGENTS GSR, COQ8A, TXNRD2 BCHE 2853/4885SNCA 766/4885ALDH1A1 1426/4885
US-10472340-B2 Substituted phenothiazines as mitochondrial agents GSR, TXN2, PCK2 BCHE 2881/4885SNCA 584/4885ALDH1A1 1279/4885
US-20220081404-A1 PHENOTHIAZINE ANALOGUES AS MITOCHONDRIAL THERAPEUTIC AGENTS GSR, COQ8A, TXNRD2 BCHE 2853/4885SNCA 766/4885ALDH1A1 1426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback